| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |